Success Story: From Tissue Engineering to I-140 NIW Approval for a Biomedical Engineering Expert
On April 15th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for an Engineer in the Field of Biomedical Engineering (Approval Notice).
General Field: Biomedical Engineering
Position at the Time of Case Filing: Engineer
Country of Origin: India
State of Residence at the Time of Filing: New Hampshire
Approval Notice Date: April 15th, 2026
Processing Time: 1 month, 13 days (Premium Processing Requested)
Case Summary:
We are pleased to share that North America Immigration Law Group successfully secured an I-140 NIW approval for the client, a biomedical engineering expert whose work focuses on designing and optimizing novel tissue engineering strategies for scaffold development and tissue integration. The petition was filed with Premium Processing at the time of filing and was approved under the EB-2 National Interest Waiver category.
The client’s proposed endeavor centered on improving the effectiveness of artificial tissue and organ replacement therapies. Through current employment as a senior print process engineer, the client continues to advance work involving 3D printing processes, lung scaffold development, and tissue engineering strategies with the potential to support organ replacement technologies and regenerative medicine. In the petition, we framed this work as nationally important because it addresses organ shortages, transplantation innovation, and broader public health needs in the United States.
To demonstrate that the client was well-positioned to advance this endeavor, we presented a record of scholarly and technical contributions, including 5 peer-reviewed journal articles, 1 abstract, 3 first-authored book chapters, and 3 patent application publications. The petition did not treat these numbers as automatically sufficient. Rather, we explained how an adjudicator could view this publication record as evidence of sustained productivity in a specialized area where research outcomes may directly inform scaffold engineering, tissue regeneration, and artificial organ development.
We also emphasized the client’s 274 citations as evidence of independent reliance by other researchers. Instead of presenting the citation count in isolation, the petition contextualized it through citation percentiles and examples showing how other experts used the client’s methods and findings in their own investigations. This helped demonstrate that the client’s work had moved beyond publication and had become useful to peers advancing related biomedical research.
The petition further highlighted that the client’s work had been supported by funding from the National Institutes of Health, the National Institute on Aging, and the Council of Scientific & Industrial Research. We used this evidence to show that the client’s research aligned with respected funding priorities in health, aging, regenerative medicine, and scientific innovation.
The case was also supported by 3 recommendation letters from experts in the field. These letters helped connect the client’s technical record to real-world significance by explaining how the client’s work contributed to biomedical engineering, tissue regeneration, and related therapeutic applications.
“I have no doubt that [Client] is a leading individual in the biomedical engineering community.”
Ultimately, the petition demonstrated the client’s significance through a combination of objective evidence, including publications, citations, patent activity, research funding, peer reliance, and expert letters. Together, these materials showed that the client was not only active in a nationally important field, but also well-positioned to continue advancing tissue engineering strategies with meaningful potential benefits for U.S. biomedical innovation and public health.